{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T20:54:15Z","timestamp":1775336055716,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"9113","license":[{"start":{"date-parts":[[1998,5,1]],"date-time":"1998-05-01T00:00:00Z","timestamp":893980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1998,5]]},"DOI":"10.1016\/s0140-6736(97)10384-1","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T01:04:53Z","timestamp":1027645493000},"page":"1393-1396","source":"Crossref","is-referenced-by-count":1352,"title":["Circulating concentrations of insulin-like growth factor I and risk of breast cancer"],"prefix":"10.1016","volume":"351","author":[{"given":"Susan E","family":"Hankinson","sequence":"first","affiliation":[]},{"given":"Walter C","family":"Willett","sequence":"additional","affiliation":[]},{"given":"Graham A","family":"Colditz","sequence":"additional","affiliation":[]},{"given":"David J","family":"Hunter","sequence":"additional","affiliation":[]},{"given":"Dominique S","family":"Michaud","sequence":"additional","affiliation":[]},{"given":"Bonnie","family":"Deroo","sequence":"additional","affiliation":[]},{"given":"Bernard","family":"Rosner","sequence":"additional","affiliation":[]},{"given":"Frank E","family":"Speizer","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Pollak","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(97)10384-1_bib1","first-page":"1509","article-title":"Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation","volume":"56","author":"Yang","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(97)10384-1_bib2","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/jnci\/82.21.1693","article-title":"Effect of tamoxifen on serum insulin-like growth factor I levels in stage I breast cancer patients","volume":"82","author":"Pollak","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0140-6736(97)10384-1_bib3","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1172\/JCI114315","article-title":"Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice","volume":"84","author":"Arteaga","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/S0140-6736(97)10384-1_bib4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/nm1097-1141","article-title":"Growth hormone treatment induces mammary gland hyperplasia in aging primates","volume":"3","author":"Ng","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/S0140-6736(97)10384-1_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0960-0760(92)90213-3","article-title":"High frequency of mammary adenocarcinomas in mettallothionein promoter-human growth hormone transgenic mice created from two different strains of mice","volume":"43","author":"Tornell","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S0140-6736(97)10384-1_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1210\/endo.137.1.8536631","article-title":"Targeted expression of des (1\u20133) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression","volume":"137","author":"Hadsell","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/S0140-6736(97)10384-1_bib7","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/bjc.1995.484","article-title":"Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF II)","volume":"72","author":"Bates","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/S0140-6736(97)10384-1_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1210\/endo.138.2.5036","article-title":"Co-expression of bovine growth hormone (GH) and human GH antagonist genes in transgenic mice","volume":"138","author":"Chen","year":"1997","journal-title":"Endocrinolog"},{"key":"10.1016\/S0140-6736(97)10384-1_bib9","first-page":"165","article-title":"Mammary gland development is impared in transgenic mice overexpressing a bovine growth hormone antagonist","volume":"79","author":"Ruan","year":"1997","journal-title":"Proceedings of the Endocrine Society 79th Annual Meeting"},{"key":"10.1016\/S0140-6736(97)10384-1_bib10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ijc.2910240409","article-title":"Serum, pituitary and urine concentrations of prolactin and growth hormone in eight strains of mice with varying incidence of mammary tumors","volume":"24","author":"Sinha","year":"1979","journal-title":"Int J Cancer"},{"key":"10.1016\/S0140-6736(97)10384-1_bib11","first-page":"744","article-title":"Serum insulin-like growth factor I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index","volume":"78","author":"Juul","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0140-6736(97)10384-1_bib12","first-page":"2534","article-title":"Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index and pubertal maturation","volume":"80","author":"Juul","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S0140-6736(97)10384-1_bib13","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.2204108","article-title":"Cell proliferation in carcinogenesis","volume":"249","author":"Cohen","year":"1990","journal-title":"Science"},{"key":"10.1016\/S0140-6736(97)10384-1_bib14","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/jnci\/87.17.1297","article-title":"Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women","volume":"87","author":"Hankinson","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0140-6736(97)10384-1_bib15","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/oxfordjournals.aje.a009065","article-title":"Epidemiology of insulin-like growth factor-I in elderly men and women","volume":"145","author":"Goodman-Gruen","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S0140-6736(97)10384-1_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/09513599309152509","article-title":"Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor I, growth hormone and sex hormone binding globulin serum levels","volume":"7","author":"Campagnoli","year":"1993","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/S0140-6736(97)10384-1_bib17","first-page":"3","article-title":"Insulin like growth factors and their binding proteins-biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/S0140-6736(97)10384-1_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ijc.2910620306","article-title":"Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable premenopausal breast cancer","volume":"62","author":"Bruning","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/S0140-6736(97)10384-1_bib19","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2307\/2531153","article-title":"Multivariate methods in ophthalmology with application to other paired-data situations","volume":"40","author":"Rosner","year":"1984","journal-title":"Biometrics"},{"key":"10.1016\/S0140-6736(97)10384-1_bib20","series-title":"Applied logistic regression","author":"Hosmer","year":"1989"},{"key":"10.1016\/S0140-6736(97)10384-1_bib21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0959-8049(05)80137-6","article-title":"Plasma insulin-like growth factor-I (IGF-I) concentrations in human breast cancer","volume":"29A","author":"Peyrat","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0140-6736(97)10384-1_bib22","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1210\/endo.136.3.7867584","article-title":"Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid","volume":"36","author":"Ruan","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/S0140-6736(97)10384-1_bib23","first-page":"4135","article-title":"Calorie restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: alterations in circulation insulin, insulin-like growth factors I and II, and epidermal growth factor","volume":"49","author":"Ruggeri","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(97)10384-1_bib24","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0140-6736(96)03102-9","article-title":"Birthweight as a risk factor for breast cancer","volume":"348","author":"Michels","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(97)10384-1_bib25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0140-6736(92)93019-J","article-title":"Evidence of prenatal influences on breast cancer risk","volume":"340","author":"Ekbom","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(97)10384-1_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0378-3782(96)01737-9","article-title":"Insulin-like growth factor (IGFs) and IGF binding proteins -1, -2 and -3 in newborn serum: relationships to fetoplacental growth at term","volume":"46","author":"Osorio","year":"1996","journal-title":"Early Hum Dev"},{"key":"10.1016\/S0140-6736(97)10384-1_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/oxfordjournals.epirev.a036096","article-title":"Diet, body size and breast cancer","volume":"15","author":"Hunter","year":"1993","journal-title":"Epidemiol Rev"},{"key":"10.1016\/S0140-6736(97)10384-1_bib28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study","volume":"279","author":"Chan","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0140-6736(97)10384-1_bib29","first-page":"523","article-title":"Increased epithelial cell proliferation in the colon of patients with acromegaly","volume":"56","author":"Cats","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(97)10384-1_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1005950916707","article-title":"Endocrine effects of insulin-like growth factor 1 on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention","volume":"47","author":"Pollak","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S0140-6736(97)10384-1_bib31","doi-asserted-by":"crossref","first-page":"12298","DOI":"10.1073\/pnas.91.25.12298","article-title":"Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone","volume":"91","author":"Zarandi","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0140-6736(97)10384-1_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3181\/00379727-217-44216","article-title":"Mechanisms of antineoplastic action of somatostatin analogues","volume":"217","author":"Pollak","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/S0140-6736(97)10384-1_bib33","series-title":"Adjuvant therapy of cancer VIII: proceedings of the eighth international conference on the adjuvent therapy of cancer","first-page":"145","article-title":"Rational for combined antiestrogen-somatostatin analogue therapy of breast cancer","author":"Pollak","year":"1996"},{"key":"10.1016\/S0140-6736(97)10384-1_bib34","first-page":"1545","article-title":"Insulin-like growth factor binding protein 3 mediates retinoic acid and transforming growth factor beta 2-induced growth inhibition in human breast cancer cells","volume":"56","author":"Gucev","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/S0140-6736(97)10384-1_bib35","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1074\/jbc.270.23.13589","article-title":"Transforming growth factorinduced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action","volume":"270","author":"Oh","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/S0140-6736(97)10384-1_bib36","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/jnci\/89.9.652","article-title":"Antiproliferative action of vitamin-D-related compounds and insulin-like growth factor binding protein 5 accumulation","volume":"89","author":"Rozen","year":"1997","journal-title":"J Natl Cancer Inst"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673697103841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673697103841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T05:25:03Z","timestamp":1555392303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673697103841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":36,"journal-issue":{"issue":"9113","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["S0140673697103841"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(97)10384-1","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}